Stay updated with breaking news from Mobility Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase two clinical trials at UT Southwestern Medical Center revealed that a suspension of gold nanocrystals taken daily by patients with multiple sclerosis (MS) and Parkinson’s disease (PD) significantly reversed deficits in metabolites linked to energy activity in the brain, resulting in functional improvements.
Results from phase two clinical trials at UT Southwestern Medical Center showed that a suspension of gold nanocrystals taken daily by patients with multiple scl
/PRNewswire/ -- According to a new market research report titled, 'Latin America Home Healthcare Market by Product (Equipment [Therapeutic {Insulin, Dialysis},...
Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Global Home Health Market By product, By services & By region-Forecast Analysis 2022-2028" report has...
The introduction of newer technologies into this market has significantly increased the current communication flow between patients and healthcare...